Literature DB >> 11103358

Management strategies for community acquired pneumonia.

M Hasnain1, E J Clark.   

Abstract

The past decade has witnessed dramatic changes in the etiology, diagnosis, and management of community acquired pneumonia (CAP). Due to the wide variation in practice patterns, physicians and professional societies have taken the lead in developing practice guidelines. To better understand the range of these multiple protocols, various stages of the disease and treatment are described and compared. Experts agree that CAP management should include: defining a correct diagnosis, identifying high risk populations in order to determine the severity of the disease, recommending appropriate treatment therapies, and obtaining positive and cost beneficial outcomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103358     DOI: 10.1023/a:1005540208406

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  16 in total

1.  The role of clinical practice guidelines in disease management.

Authors:  J M Henning
Journal:  Am J Manag Care       Date:  1998-12       Impact factor: 2.229

2.  Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.

Authors:  P P Gleason; W N Kapoor; R A Stone; J R Lave; D S Obrosky; R Schulz; D E Singer; C M Coley; T J Marrie; M J Fine
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

3.  Death rates among patients hospitalized with community-acquired pneumonia: a reexamination with data from three states.

Authors:  J S Markowitz; S Pashko; E M Gutterman; W T Linde-Zwirble; R Newbold
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

4.  Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

Authors:  B J Marston; J F Plouffe; T M File; B A Hackman; S J Salstrom; H B Lipman; M S Kolczak; R F Breiman
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

5.  Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.

Authors:  J G Bartlett; R F Breiman; L A Mandell; T M File
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

6.  Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.

Authors:  J E Stahl; M Barza; J DesJardin; R Martin; M H Eckman
Journal:  Arch Intern Med       Date:  1999-11-22

7.  Quality of care, process, and outcomes in elderly patients with pneumonia.

Authors:  T P Meehan; M J Fine; H M Krumholz; J D Scinto; D H Galusha; J T Mockalis; G F Weber; M K Petrillo; P M Houck; J M Fine
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

Review 8.  Community-acquired pneumonia. Tailoring management of adult patients according to risk category.

Authors:  J B Rubins; E N Janoff
Journal:  Postgrad Med       Date:  1997-12       Impact factor: 3.840

9.  Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia.

Authors:  K Gilbert; P P Gleason; D E Singer; T J Marrie; C M Coley; D S Obrosky; J R Lave; W N Kapoor; M J Fine
Journal:  Am J Med       Date:  1998-01       Impact factor: 4.965

Review 10.  Community-acquired pneumonia.

Authors:  J P Lynch; F J Martinez
Journal:  Curr Opin Pulm Med       Date:  1998-05       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.